Ventricular Stiffening and Chamber Contracture in Heart Failure with Higher Ejection Fraction
Dejana Popović(University of Belgrade), Barry A. Borlaug(Mayo Clinic), Yogesh N.V. Reddy(Mayo Clinic), Hidemi Sorimachi(Gunma University), Daniel Burkhoff(Columbia University Irving Medical Center), Kazunori Omote(Mayo Clinic in Arizona), Massar Omar(Mayo Clinic), Alessio Alogna(Deutsches Herzzentrum der Charité), Margaret M. Redfield(Mayo Clinic in Arizona)
Cited by 65
Related Papers
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
|Circulation Heart Failure|2010|1.1k
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
|European Heart Journal|2010|1.1k
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
|Circulation|2015|848
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction
|JACC Heart Failure|2014|444